品牌 | 货号 | 包装单位 | 货期 | CAS | 产品名称 | 质量规格 | 单价(¥) | 购买数量 |
---|---|---|---|---|---|---|---|---|
罗恩 | R024937-1g | 1g | 现货 | 29342-05-0 |
6-环己基-1-羟基-4-甲基-2(1H)-吡啶酮 6-Cyclohexyl-1-hydroxy-4-me... |
99% |
|
|
罗恩 | R024937-5g | 5g | 现货 | 29342-05-0 |
6-环己基-1-羟基-4-甲基-2(1H)-吡啶酮 6-Cyclohexyl-1-hydroxy-4-me... |
99% |
|
|
罗恩 | R024937-25g | 25g | 5~7个工作日 | 29342-05-0 |
6-环己基-1-羟基-4-甲基-2(1H)-吡啶酮 6-Cyclohexyl-1-hydroxy-4-me... |
99% |
|
|
罗恩 | R024937-100g | 100g | 5~7个工作日 | 29342-05-0 |
6-环己基-1-羟基-4-甲基-2(1H)-吡啶酮 6-Cyclohexyl-1-hydroxy-4-me... |
99% |
|
|
阿拉丁 | C129264-50mg | 50mg | 现货 | 29342-05-0 |
环吡酮胺 Ciclopirox |
Moligand™, ≥99% |
|
|
阿拉丁 | C129264-250mg | 250mg | 现货 | 29342-05-0 |
环吡酮胺 Ciclopirox |
Moligand™, ≥99% |
|
|
阿拉丁 | C129264-1g | 1g | 现货 | 29342-05-0 |
环吡酮胺 Ciclopirox |
Moligand™, ≥99% |
|
|
阿拉丁 | C129264-5g | 5g | 现货 | 29342-05-0 |
环吡酮胺 Ciclopirox |
Moligand™, ≥99% |
|
|
阿拉丁 | C129264-25g | 25g | 现货 | 29342-05-0 |
环吡酮胺 Ciclopirox |
Moligand™, ≥99% |
|
|
阿拉丁 | C129264-100g | 100g | 现货 | 29342-05-0 |
环吡酮胺 Ciclopirox |
Moligand™, ≥99% |
|
|
阿拉丁 | C408974-1ml | 1ml | 现货 | 29342-05-0 |
Ciclopirox Ciclopirox |
Moligand™, 10mM in DMSO |
|
|
韶远 | SY102316-10g | 10g | 现货 | 29342-05-0 |
6-环己基-1-羟基-4-甲基吡啶-2(1H)-酮 6-Cyclohexyl-1-hydroxy-4-met... |
≥95% |
|
|
阿法埃莎 | C46343-1GR | 1GR | 现货 | 29342-05-0 |
Ciclopirox Ciclopirox |
|
|
|
阿法埃莎 | C46343-5GR | 5GR | 现货 | 29342-05-0 |
Ciclopirox Ciclopirox |
|
|
|
毕得 | BD41568-1g | 1g | 现货 | 29342-05-0 |
6-环己基-1-羟基-4-甲基-2(1H)-吡啶酮 6-Cyclohexyl-1-hydroxy-4-met... |
97% |
|
|
毕得 | BD41568-5g | 5g | 现货 | 29342-05-0 |
6-环己基-1-羟基-4-甲基-2(1H)-吡啶酮 6-Cyclohexyl-1-hydroxy-4-met... |
97% |
|
|
毕得 | BD41568-10g | 10g | 现货 | 29342-05-0 |
6-环己基-1-羟基-4-甲基-2(1H)-吡啶酮 6-Cyclohexyl-1-hydroxy-4-met... |
97% |
|
|
毕得 | BD41568-25g | 25g | 现货 | 29342-05-0 |
6-环己基-1-羟基-4-甲基-2(1H)-吡啶酮 6-Cyclohexyl-1-hydroxy-4-met... |
97% |
|
|
毕得 | BD41568-100g | 100g | 现货 | 29342-05-0 |
6-环己基-1-羟基-4-甲基-2(1H)-吡啶酮 6-Cyclohexyl-1-hydroxy-4-met... |
97% |
|
|
Acros | 463430010 | 1GR | 现货 | 29342-05-0 |
Ciclopirox Ciclopirox |
|
|